Drug Profile
Interleukin-2 microencapsulated - Carlina Technologies
Alternative Names: PEPTIDOTS-IL2Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Carlina Technologies
- Class Adjuvants; Antineoplastics; Immunotherapies; Interleukins; Lymphokines
- Mechanism of Action Immunostimulants; Interleukin-2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Renal cell carcinoma; Skin cancer
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for research development in Renal-cell-carcinoma in France (SC, Injection)
- 28 Dec 2018 No recent reports of development identified for research development in Skin-cancer in France (SC, Injection)
- 06 Nov 2014 Early research in Renal cell carcinoma in France (SC)